Five Cocrystal Forms of Antitumor Drug Temozolomide with <i>p</i>-Hydroxybenzoic Acid: Structure, Computational Analysis, Characterizations, Stability, and Transformation-Reference-Cited by-同舟云学术

Five Cocrystal Forms of Antitumor Drug Temozolomide with p-Hydroxybenzoic Acid: Structure, Computational Analysis, Characterizations, Stability, and Transformation

Published:2022-11-14 Issue:12 Volume:22 Page:7195-7206
ISSN:1528-7483
Container-title:Crystal Growth & Design
language:en
Short-container-title:Crystal Growth & Design

Author:

Yu Hongmei¹^ORCID,Zhang Baoxi¹^ORCID,Xing Wenhui¹,Liu Meiju¹,Yang Dezhi¹^ORCID,He Guorong²,Wang Fengfeng³,Zhang Li¹^ORCID,Gong Ningbo¹,Lu Yang¹^ORCID,Du Guanhua²

Affiliation:

1. Beijing Key Laboratory of Polymorphic Drugs, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China

2. Beijing City Key Laboratory of Drug Target Identification and Drug Screening, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College. Beijing 100050, China

3. National Institutes for Food and Drug Control, Beijing 102629, China

Funder

Government of Shandong Province

Natural Science Foundation of Beijing Municipality

Central University Basic Research Fund of China

Chinese Pharmacopoeia Commission Drug Standard Promoting Fund

Publisher

American Chemical Society (ACS)

Subject

Condensed Matter Physics,General Materials Science,General Chemistry

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.cgd.2c00866